|  | MAST+ RECON (n = 205) | BCT (n = 205) | MAST (n = 205) | p value |
---|---|---|---|---|---|
 |  | No.(%) | No.(%) | No.(%) |  |
Age,year |  | 38.63 ±6.94 | 38.60 ±7.58 | 39.03 ±7.21 | 0.801 |
Health-care insurance | Provincial medical insurance | 13 (6.34) | 12 (5.85) | 11 (5.37) | 0.359 |
City medical insurance | 102 (49.76) | 100 (48.78) | 119 (58.05) | Â | |
Other | 90 (43.90) | 93 (45.37) | 75 (36.59) | Â | |
Lesion location | Left breast | 110 (53.66) | 112 (54.63) | 109 (53.17) | 0.687 |
Right breast | 95 (46.34) | 93 (45.37) | 95 (46.34) | Â | |
Double breast | 0 (0.00) | 0 (0.00) | 1 (0.49) | Â | |
Histology type | Ductal carcinoma in situ | 10 (4.88) | 5 (2.44) | 6 (2.93) | 0.692 |
Invasive ductal carcinoma | 158 (77.07) | 168 (81.95) | 164 (80.00) | Â | |
Invasive lobular carcinoma | 5 (2.44) | 3 (1.46) | 2 (0.98) | Â | |
Other | 32 (15.61) | 29 (14.15) | 33 (16.10) | Â | |
TNM stage | 0 | 4 (1.95) | 3 (1.46) | 7 (3.41) | 0.513 |
I | 6 (2.93) | 5 (2.44) | 6 (2.93) | Â | |
II | 195 (95.12) | 197 (96.10) | 192 (93.66) | Â | |
BMI,Kg/m2 | <18.5 | 21 (10.24) | 15 (7.32) | 15 (7.32) | 0.261 |
18.5 ~ 23.9 | 144 (70.24) | 164 (80.00) | 148 (72.20) |  | |
>23.9 | 40 (19.51) | 26 (12.68) | 42 (20.49) | Â | |
Hormone receptor | Positive | 105 (51.22) | 106 (51.71) | 195 (66.10) | 0.993 |
Negative | 19 (9.27) | 17 (8.29) | 21 (7.12) | Â | |
Mixed | 73 (35.61) | 75 (36.59) | 73 (24.75) | Â | |
Unkonwn / missing | 8 (3.90) | 7 (3.41) | 6 (2.03) | Â | |
Patient source | In this city | 126 (61.46) | 129 (62.93) | 131 (63.90) | 0.899 |
In this province | 71 (34.63) | 65 (31.71) | 66 (32.20) | Â | |
Other | 8 (3.90) | 11 (5.37) | 8 (3.90) | Â | |
Neoadjuvant chemotherapy | No | 165 (80.49) | 169 (82.44) | 169 (82.44) | 0.840 |
Yes | 40 (19.51) | 36 (17.56) | 36 (17.56) | Â | |
Targeted therapy | No | 167 (81.46) | 172 (83.90) | 171 (83.41) | 0.786 |
Yes | 38 (18.54) | 33 (16.10) | 34 (16.59) | Â |